This next-generation test takes your existing biopsy tissue and provides a highly detailed analysis for Non-Hodgkin’s Lymphoma. Using a Custom IHC Panel, the lab applies precise “smart stains” to detect specific protein markers on the abnormal cells. This reveals not only the exact subtype of lymphoma but also offers crucial insights into which targeted therapies—like immunotherapy or chemotherapy—are likely to be most effective. By going beyond a basic diagnosis, this test gives your doctor a comprehensive blueprint for personalized treatment. It represents the pinnacle of precision medicine, ensuring that your care plan is tailored specifically to your disease and improving the chances of optimal outcomes.